Literature DB >> 29887417

Inflammation and Atrial Electrical Remodelling in Patients With Embolic Strokes of Undetermined Source.

Maurizio Acampa1, Pietro Enea Lazzerini2, Francesca Guideri3, Rossana Tassi3, Andrea Lo Monaco3, Giuseppe Martini3.   

Abstract

BACKGROUND: About one third of ischaemic strokes are classified as embolic strokes of undetermined source (ESUS). A silent atrial fibrillation (AF) may play a pathogenic role in these strokes and P wave dispersion (PWD), representing an electrocardiographic (ECG) predictor for paroxysmal AF, thereby a potential marker of covert cardioembolism, was found to be increased in cryptogenic stroke. Furthermore, current evidence links AF to inflammation: inflammatory markers, such as high-sensitive C-reactive protein (hsCRP), have been related to the development and persistence of AF, possibly by promoting atrial remodelling. The aim of this study was to evaluate whether a relationship between PWD and hsCRP in patients with ESUS exists, in order to highlight a possible role for inflammation in the atrial electric remodelling, that predisposes to AF.
METHODS: We enrolled 174 patients (91 males, 83 females; mean age 69±13years) with ESUS. All patients underwent neuroimaging examination, arterial ultrasound examination, echocardiography and ECG. P wave dispersion and hsCRP were measured in all subjects.
RESULTS: A significant positive correlation was found between hsCRP and PWD (Spearman r: 0.35, p<0.0001). In patients with high PWD (>40 msec; n=102), hsCRP was three-fold higher than in patients with normal PWD (≤40 msec; n=72)(1.57±2.9 vs 0.42±0.4mg/dl, p=0.0005).
CONCLUSIONS: Our results show increased hsCRP levels in cryptogenic stroke patients with high PWD. These findings provide support for the hypothesis that systemic inflammation plays a role in a fraction of patients with ESUS, by increasing AF risk via atrial electric remodelling.
Copyright © 2018 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; ECG; ESUS; Inflammation; Ischaemic stroke; P wave dispersion

Mesh:

Year:  2018        PMID: 29887417     DOI: 10.1016/j.hlc.2018.04.294

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  7 in total

1.  A Nomogram for Predicting Patent Foramen Ovale-Related Stroke Recurrence.

Authors:  Zhuonan Wu; Chuanjing Zhang; Nan Liu; Wenqing Xie; Jinjin Yang; Hangyuan Guo; Jufang Chi
Journal:  Front Neurol       Date:  2022-06-09       Impact factor: 4.086

2.  Atrial Cardiopathy and Sympatho-Vagal Imbalance in Cryptogenic Stroke: Pathogenic Mechanisms and Effects on Electrocardiographic Markers.

Authors:  Maurizio Acampa; Pietro E Lazzerini; Giuseppe Martini
Journal:  Front Neurol       Date:  2018-06-19       Impact factor: 4.003

3.  The Use of Novel Non-Vitamin K Antagonist Oral Anticoagulants Following Closure of the Left Atrial Appendage: Preliminary Results of Clinical Follow-Up.

Authors:  Jing Zhu; Jian Xu
Journal:  Drug Des Devel Ther       Date:  2021-03-09       Impact factor: 4.162

4.  Anterior Circulation Acute Ischemic Stroke in the Plateau of China: Risk Factors and Clinical Characteristics.

Authors:  Yujia Yan; Xiqiang Zhang; Hecheng Ren; Xingwei An; Wanpeng Fan; Jingbo Liang; Ying Huang
Journal:  Front Neurol       Date:  2022-04-13       Impact factor: 4.003

5.  Markers of Atrial Cardiopathy in Severe Embolic Strokes of Undetermined Source.

Authors:  Maurizio Acampa; Alessandra Cartocci; Carlo Domenichelli; Rossana Tassi; Francesca Guideri; Pietro Enea Lazzerini; Giuseppe Martini
Journal:  Front Cardiovasc Med       Date:  2022-06-20

Review 6.  Evidence for Inflammation as a Driver of Atrial Fibrillation.

Authors:  Xiaoxu Zhou; Samuel C Dudley
Journal:  Front Cardiovasc Med       Date:  2020-04-29

7.  Association of Interleukin-6-174G/C Polymorphism With Ischemic Stroke: An Updated Meta-Analysis.

Authors:  Jie Chai; Xian-Ling Cao; Feng Lu
Journal:  Front Neurol       Date:  2022-01-06       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.